Structural basis of drug recognition by human MATE1 transporter

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Human MATE1 (multidrug and toxin extrusion protein 1) is highly expressed in the kidney and liver.
• It plays a key role in the excretion of cationic drugs, impacting drug clearance and efficacy.
• Understanding MATE1's drug recognition is vital for optimizing therapies and predicting drug-drug interactions.

Purpose of the Study:

• To elucidate the molecular basis of drug recognition by the human MATE1 transporter.
• To determine the structural mechanisms underlying MATE1's substrate specificity.

Main Methods:

• Cryo-electron microscopy (cryo-EM) was used to determine the structures of hMATE1 in complex with substrates (MPP, metformin) and an inhibitor (cimetidine).
• Radioactivity-based cellular uptake assays with hMATE1 mutants were performed for functional validation.
• Molecular dynamics (MD) simulations were employed to analyze ligand binding modes and transporter dynamics.

Main Results:

• Cryo-EM structures revealed a shared binding site within a negatively charged pocket in the C-lobe of hMATE1.
• Key interactions between hMATE1 and its substrates/inhibitors were functionally validated through mutagenesis and uptake assays.
• MD simulations provided insights into the dynamic behavior of ligands within the binding pocket.

Conclusions:

• The study defines the structural basis for hMATE1's substrate specificity.
• These findings illuminate hMATE1's role in drug transport and the mechanisms underlying drug-drug interactions.